Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lotus Eye Hospital & InstituteBOM:532998 -0.97%72 ROC (Joel Greenblatt) % is 9.10% as of Jun. 2026, which is 139% above its 10-year median of 3.81. GuruFocus rates BOM:532998 with a GF Score™ of 72/100 and a GF Value™ of ₹98.30 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 674 Healthcare Providers & Services companies, Lotus Eye Hospital & Institute ranks worse than 66.32% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Lotus Eye Hospital & Institute's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 9.10%.
The historical rank and industry rank for Lotus Eye Hospital & Institute's ROC (Joel Greenblatt) % or its related term are showing as below:
BOM:532998'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.13 Med: 3.81 Max: 12.82
Current: 2.48
During the past 13 years, Lotus Eye Hospital & Institute's highest ROC (Joel Greenblatt) % was 12.82%. The lowest was 1.13%. And the median was 3.81%.
BOM:532998's ROC (Joel Greenblatt) % is ranked worse than 66.32% of 674
companies
in the Healthcare Providers & Services industry
Industry Median: 12.5
vs BOM:532998: 2.48
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lotus Eye Hospital & Institute ROC (Joel Greenblatt) % Chart
BOM:532998 vs HCA, THC, DVA: ROC (Joel Greenblatt) % Comparison
For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lotus Eye Hospital & Institute ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Lotus Eye Hospital & Institute's ROC (Joel Greenblatt) % falls into.
Lotus Eye Hospital & Institute ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 9.10% mean?
Lotus Eye Hospital & Institute (BOM:532998) has a ROC (Joel Greenblatt) % of 9.10% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Lotus Eye Hospital & Institute and its competitors. This is 139% above median its historical median of 3.81. Over the past decade, Lotus Eye Hospital & Institute's ROC (Joel Greenblatt) % has ranged from 1.13 to 12.82. According to the industry distribution chart, Lotus Eye Hospital & Institute ranks #447 out of 674 companies in the Healthcare Providers & Services industry, placing it in the top 66.3%.
Is Lotus Eye Hospital & Institute's ROC (Joel Greenblatt) % too high?
Lotus Eye Hospital & Institute's current ROC (Joel Greenblatt) % of 9.10% is 139% above median its 10-year median of 3.81. Over the past 10 years, this metric has ranged from a low of 1.13 to a high of 12.82. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.50. Lotus Eye Hospital & Institute's value of 9.10% is 27.2% below this industry median. Based on the distribution chart, Lotus Eye Hospital & Institute ranks #447 out of 674 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's ROC (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Lotus Eye Hospital & Institute ranks #447 out of 674 companies for ROC (Joel Greenblatt) %. This places Lotus Eye Hospital & Institute in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 12.50. Lotus Eye Hospital & Institute's value of 9.10% is 27.2% below this benchmark. Historically, Lotus Eye Hospital & Institute's own ROC (Joel Greenblatt) % has ranged from 1.13 to 12.82 over the past decade. While the company's 10-year median is 3.81 vs. the industry median of 12.50, Lotus Eye Hospital & Institute has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.50, based on 674 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lotus Eye Hospital & Institute's current ROC (Joel Greenblatt) % of 9.10% is 27.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Lotus Eye Hospital & Institute and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Eye Hospital & Institute's current ROC (Joel Greenblatt) % is 9.10%, which is 139% above median its own 10-year median of 3.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹98.30, compared to a current price of ₹112.70 — trading 14.6% above its estimated fair value. The current ROC (Joel Greenblatt) % is 9.10%, which is 139% above median its 10-year median of 3.81 and 27.2% below the Healthcare Providers & Services industry median of 12.50. Lotus Eye Hospital & Institute's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current ROC (Joel Greenblatt) % is 9.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued.
The current stock price of ₹112.70 is trading 14.6% above its estimated GF Value™ of ₹98.30.
GuruFocus considers Lotus Eye Hospital & Institute to be Modestly Overvalued.
Key valuation signals for BOM:532998:
ROC (Joel Greenblatt) %: 9.10% (139% above median its 10-year median of 3.81)
GF Value™: ₹98.30 vs. price of ₹112.70 (14.6% above fair value)
Industry Position: 27.2% below the Healthcare Providers & Services median (#447 of 674)
No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
72GF Score
Get the complete analysis for BOM:532998
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532998 has been successfully added to your 
